Last reviewed · How we verify

NCT06640205

Assessment of I-PRF Versus Nano MTA Combined with I-PRF Scaffold in Vital Pulp Therapy in Mature Mandibular First Molars

Recruiting now NA Last updated 15 October 2024
What this trial tests

NA trial testing pulpotomy in Pulpotomy in 51 participants. Currently enrolling.

Timeline
3 September 2023
Primary endpoint
2 September 2024
2 September 2025

Quick facts

Lead sponsorFuture University in Egypt
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment51
Start date3 September 2023
Primary completion2 September 2024
Estimated completion2 September 2025
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Future University in Egypt

Who can join

Adults 15 to 30, any sex, with Pulpotomy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Assessment of I-PRF versus Nano Mineral trioxide aggregate Combined with I-PRF in pulpotomy in mature Mandibular First Molars

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of pulpotomy

Trials testing the same drug.

Other recruiting trials for Pulpotomy

Currently open trials in the same condition.

Other Future University in Egypt trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06640205.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing